Sirtuins: The Longevity Genes and What Actually Activates Them
Sirtuins are a family of seven NAD+-dependent enzymes that regulate gene expression, DNA repair, metabolism, inflammation, and stress resistance - and raising their activity extends lifespan in some laboratory organisms, though several of those findings have been disputed. They are the molecular targets of caloric restriction, resveratrol, and NAD+ precursor supplementation. Understanding what sirtuins actually do - and what genuinely activates them - cuts through considerable mythology that surrounds these proteins.
- Sirtuins are NAD+-dependent deacylases - enzymes that remove acetyl and other acyl groups from lysine residues on histone and non-histone proteins, regulating gene expression and protein function in a way that is directly coupled to cellular energy status via NAD+ availability.
- The seven mammalian sirtuins (SIRT1-7) are distributed across the nucleus, cytoplasm, and mitochondria with distinct substrates and functions. SIRT1 and SIRT3 are the most studied in the context of longevity - SIRT1 regulates chromatin structure and stress response genes; SIRT3 regulates mitochondrial protein acetylation and oxidative metabolism.
- Sirtuins require NAD+ as a co-substrate - not merely a cofactor. Each deacylation reaction consumes one molecule of NAD+, producing nicotinamide (a SIRT1 inhibitor) and O-acetyl-ADP-ribose. This means sirtuin activity is directly limited by cellular NAD+ availability, which declines with age. Restoring NAD+ via NMN or NR supplementation should, in theory, restore sirtuin activity.
- Resveratrol - the polyphenol found in red wine - was proposed to activate SIRT1 directly in 2003, generating enormous excitement and launching multiple pharmaceutical programs. Later work showed that much of the apparent activation depended on a fluorescent tag used in the test, which deflated the resveratrol story, though some later studies report direct activation with particular substrates.
- Calorie restriction, exercise and fasting raise sirtuin activity in animal studies, and NMN and NR raise NAD+ levels in people, but there is little direct evidence that any of them boost sirtuin activity in humans in ways that improve health.
Sirtuin biology entered the popular consciousness with two developments: yeast studies around 2000 from Leonard Guarente’s lab showing that the sirtuin Sir2 extends yeast lifespan and is needed for the benefits of calorie restriction, and the 2003 paper by Howitz, Sinclair, and colleagues proposing that resveratrol activated the mammalian sirtuin SIRT1 and extended yeast lifespan - directly connecting red wine to longevity biology and generating a media frenzy that has not entirely subsided. The sirtuin story since then has been considerably more complicated, more interesting, and more honest than the original headlines suggested.1
What Sirtuins Actually Are
Sirtuins are a conserved family of enzymes defined by their requirement for NAD+ as a co-substrate for their catalytic activity. In mammals, seven sirtuins (SIRT1-7) are expressed with different subcellular localizations and substrate specificities. The primary biochemical reaction catalyzed by classical sirtuins (SIRT1-3) is deacetylation - removal of acetyl groups from lysine residues on histone and non-histone proteins. Histone deacetylation generally compacts chromatin and silences gene expression; protein deacetylation can activate or inhibit specific proteins depending on the substrate.2
The NAD+ dependence is the mechanistically critical feature. Unlike most enzymatic reactions where the cofactor is regenerated catalytically, each sirtuin deacetylation reaction consumes one molecule of NAD+ stoichiometrically - producing nicotinamide (which is itself a feedback inhibitor of sirtuin activity) and O-acetyl-ADP-ribose as co-products. This means sirtuin activity is directly and sensitively coupled to cellular NAD+ availability. When NAD+ levels are high (caloric restriction, fasting, exercise), sirtuin activity is elevated. When NAD+ levels are low (aging, overnutrition, sedentary lifestyle), sirtuin activity is reduced.
SIRT1: The Master Longevity Regulator
SIRT1 is the most extensively studied mammalian sirtuin. It is located primarily in the nucleus and deacetylates histones H3K9 and H4K16 (promoting chromatin compaction and gene silencing), p53 (inhibiting apoptosis and cellular senescence), NF-kB (reducing inflammatory gene expression), FOXO transcription factors (activating stress resistance and autophagy genes), and PGC-1 alpha (activating mitochondrial biogenesis). SIRT1 is a convergence point for multiple longevity pathways - it is activated by caloric restriction, mediates many of the anti-inflammatory effects of exercise, and promotes the epigenetic stability of chromatin that declines with aging.3
SIRT3: The Mitochondrial Longevity Regulator
SIRT3 is the primary mitochondrial sirtuin, deacetylating and activating key enzymes of oxidative metabolism: complexes of the electron transport chain, enzymes of the TCA cycle, fatty acid oxidation enzymes, and manganese superoxide dismutase (the primary mitochondrial antioxidant enzyme). Mice lacking SIRT3 show widespread changes in mitochondrial protein acetylation and, under stresses such as a high-fat diet, metabolic problems, supporting its role in metabolism. SIRT3 activity declines significantly with aging in mice, and this decline correlates with the mitochondrial dysfunction characteristic of aging muscle.4
The Resveratrol Story: A Correction
The 2003 paper proposing that resveratrol directly activated SIRT1 was one of the most cited papers in aging science and launched Sirtris Pharmaceuticals (acquired by GlaxoSmithKline for 720 million dollars in 2008) and multiple pharmaceutical programs targeting SIRT1. Subsequent biochemical work by Borra, Kaeberlein, and others established that the original resveratrol-SIRT1 activation data was an artifact of the fluorophore attached to the peptide substrate used in the assay - resveratrol does not directly activate SIRT1 against native peptide substrates. In cell and animal studies resveratrol can raise SIRT1 activity indirectly, through AMPK, but the original direct-activation story did not hold up as first described. GSK terminated the Sirtris programs in 2013.5
Resveratrol is not worthless - it has genuine AMPK-activating and anti-inflammatory effects - but it is not a direct sirtuin activator, and the longevity claims built on the original mechanistic story were overstated. The interventions with the best health evidence in people, such as regular exercise and avoiding overeating, are worth doing for their own sake; whether they work through sirtuins is still unproven.
References
- 1Guarente L. "Sirtuins in aging and disease." Cold Spring Harb Symp Quant Biol. 2007;72:483-8. PubMed · DOI
- 2Haigis MC, Guarente LP. "Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction." Genes Dev. 2006;20(21):2913-21. PubMed · DOI
- 3Bordone L, Guarente L. "Calorie restriction, SIRT1 and metabolism: understanding longevity." Nat Rev Mol Cell Biol. 2005;6(4):298-305. PubMed · DOI
- 4Lombard DB, et al. "Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation." Mol Cell Biol. 2007;27(24):8807-14. PubMed · DOI
- 5Kaeberlein M, et al. "Substrate-specific activation of sirtuins by resveratrol." J Biol Chem. 2005;280(17):17038-45. PubMed · DOI
